Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer.
Rosenberg AJ, Wainwright DA, Rademaker A, Galvez C, Genet M, Zhai L, Lauing KL, Mulcahy MF, Hayes JP, Odell DD, Horbinski C, Komanduri S, Tetreault MP, Kim KA, Villaflor VM.
Rosenberg AJ, et al. Among authors: kim ka.
Oncotarget. 2018 May 4;9(34):23482-23493. doi: 10.18632/oncotarget.25235. eCollection 2018 May 4.
Oncotarget. 2018.
PMID: 29805749
Free PMC article.